This SolarEdge Technologies Analyst Turns Bearish Here Are Top 5 Downgrades For Friday

POAI Stock  USD 0.80  0.05  6.67%   
Under 67 percent of all Predictive Oncology's traders are curious in acquiring. The analysis of overall sentiment of trading Predictive Oncology stock suggests that a large number of investors are confidant at this time. Predictive Oncology's investing sentiment shows overall attitude of investors towards Predictive Oncology.
  

Read at benzinga.com
benzinga news
  

Predictive Oncology Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Predictive Oncology can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Predictive Oncology Fundamental Analysis

We analyze Predictive Oncology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Predictive Oncology using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Predictive Oncology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Working Capital

Working Capital Comparative Analysis

Predictive Oncology is currently under evaluation in working capital category among its peers. Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .

Predictive Oncology Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Predictive Oncology stock to make a market-neutral strategy. Peer analysis of Predictive Oncology could also be used in its relative valuation, which is a method of valuing Predictive Oncology by comparing valuation metrics with similar companies.

Peers

Predictive Oncology Related Equities

MLSSMilestone Scientific   26.58   
0%
100.0%
STSSSharps Technology   9.07   
0%
34.0%
PDEXPro Dex   2.55   
0%
9.0%
STXSStereotaxis   1.33   
0%
5.0%
ISRGIntuitive Surgical   1.03   
0%
3.0%
MBOTMicrobot Medical   1.02   
0%
3.0%
LUCYInnovative Eyewear   0.29   
0%
1.0%
NYXHNyxoah   0.73   
2.0%
0%
DXRDaxor   3.44   
12.0%
0%
GCTKGlucoTrack   3.85   
14.0%
0%
BNGOBionano Genomics   4.00   
15.0%
0%
NXGLNexgel   4.15   
15.0%
0%
ZJYLJIN MEDICAL   7.37   
27.0%
0%

Complementary Tools for Predictive Stock analysis

When running Predictive Oncology's price analysis, check to measure Predictive Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Predictive Oncology is operating at the current time. Most of Predictive Oncology's value examination focuses on studying past and present price action to predict the probability of Predictive Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Predictive Oncology's price. Additionally, you may evaluate how the addition of Predictive Oncology to your portfolios can decrease your overall portfolio volatility.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume